ARTICLE | Distillery Therapeutics
FOXI1, CAII inhibition to treat tuberous sclerosis complex-associated kidney cysts
February 26, 2021 10:12 PM UTC
DISEASE CATEGORY: Renal
INDICATION: Renal damage...
BCIQ Company Profiles
DISEASE CATEGORY: Renal
INDICATION: Renal damage...
BCIQ Company Profiles
BCIQ Company Profiles